REQUEST A DEMO
Total
USD $0.00
Search more companies

Damjan es Kozma Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: DAMJAN es KOZMA Gyogyszerkereskedelmi Bt. Profile Updated: October 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Damjan es Kozma Bt. is an enterprise located in Hungary, with the main office in Budapest. The enterprise currently operates in the Pharmacies and Drug Stores sector. It was first established on January 08, 1996. It currently has a total number of 4 (2024) employees. In its most recent financial highlights, the company reported a net sales revenue drop of 4.69% in 2023. Its’ total assets recorded a growth of 10.02%. Damjan es Kozma Bt.’s net profit margin increased by 1.27% in 2023.

Headquarters
Etele u. 30.
Budapest; Budapest; Postal Code: 1119

Contact Details: Purchase the Damjan es Kozma Bt. report to view the information.

Basic Information
Total Employees:
Purchase the Damjan es Kozma Bt. report to view the information.
Outstanding Shares:
Purchase the Damjan es Kozma Bt. report to view the information.
Registered Capital:
Purchase the Damjan es Kozma Bt. report to view the information.
Financial Auditors:
Purchase the Damjan es Kozma Bt. report to view the information.
Incorporation Date:
January 08, 1996
Key Executives
Purchase this report to view the information.
Executive Officer
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Damjan es Kozma Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
-4.69%
Total operating revenue
-4.47%
Operating profit (EBIT)
67.82%
EBITDA
65.08%
Net Profit (Loss) for the Period
140.36%
Total assets
10.02%
Total equity
17.06%
Operating Profit Margin (ROS)
1.22%
Net Profit Margin
1.27%
Return on Equity (ROE)
7.47%
Quick Ratio
0.26%
Cash Ratio
0.25%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?